Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.
作者信息
Van Thiel D H, Iqbal M, Jain A, Fung J, Todo S, Starzl T E
机构信息
Department of Surgery, University of Pittsburgh, PA.
出版信息
Transplant Proc. 1990 Feb;22(1):37-40.
Abstract
摘要
相似文献
1
Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.
Transplant Proc. 1990 Feb;22(1):37-40.
2
Pathologic observations in human allograft recipients treated with FK 506.
Transplant Proc. 1990 Feb;22(1):25-34.
3
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
Transplant Proc. 1990 Feb;22(1):6-12.
4
A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent.
Transplant Proc. 1990 Feb;22(1):47-9.
5
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.
Transplant Proc. 1991 Feb;23(1 Pt 2):1397-402.
6
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population.
Transplant Proc. 1991 Feb;23(1 Pt 2):1108-10.
7
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
Transplant Proc. 1991 Feb;23(1 Pt 1):14-21.
8
The effects of FK 506 on renal function after liver transplantation.
Transplant Proc. 1990 Feb;22(1):17-20.
9
The question of FK 506 nephrotoxicity after liver transplantation.
Transplant Proc. 1991 Feb;23(1 Pt 2):1444-7.
10
The side effects of FK 506 in humans.
Transplant Proc. 1990 Feb;22(1):35-6.
引用本文的文献
1
Gout Due to Tacrolimus in a Liver Transplant Recipient.
Cureus. 2019 Mar 13;11(3):e4247. doi: 10.7759/cureus.4247.
2
Pediatric liver transplantation.
World J Gastroenterol. 2009 Feb 14;15(6):648-74. doi: 10.3748/wjg.15.648.
3
Gout in solid organ transplantation: a challenging clinical problem.
Drugs. 2005;65(18):2593-611. doi: 10.2165/00003495-200565180-00004.
4
Immunosuppressive drugs in paediatric liver transplantation.
Paediatr Drugs. 2001;3(1):43-60. doi: 10.2165/00128072-200103010-00004.
5
History of clinical transplantation.
World J Surg. 2000 Jul;24(7):759-82. doi: 10.1007/s002680010124.
6
Kidney transplantation under FK 506.
JAMA. 1990 Jul 4;264(1):63-7.
本文引用的文献
1
Cyclophilin: a specific cytosolic binding protein for cyclosporin A.
Science. 1984 Nov 2;226(4674):544-7. doi: 10.1126/science.6238408.
2
Action and toxicity of cyclosporine.
Annu Rev Med. 1986;37:215-24. doi: 10.1146/annurev.me.37.020186.001243.
3
Effects of cyclosporine therapy on plasma lipoprotein levels.
JAMA. 1989 Jul 7;262(1):53-6.
4
Cyclosporine-induced hyperuricemia and gout.
N Engl J Med. 1989 Aug 3;321(5):287-92. doi: 10.1056/NEJM198908033210504.
5
Renal transplantation in baboons under FK 506.
Surgery. 1989 Aug;106(2):444-50; discussion 450-1.
6
7
Toxicology of FK-506 in the Lewis rat.
Transplant Proc. 1987 Oct;19(5 Suppl 6):89-92.
8
Orthotopic liver transplantation in dogs receiving FK-506.
Transplant Proc. 1987 Oct;19(5 Suppl 6):64-7.
9
Kidney transplantation in the dog receiving FK-506.
Transplant Proc. 1987 Oct;19(5 Suppl 6):62.
10
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.
Transplant Proc. 1987 Oct;19(5 Suppl 6):57-61.
Zotero 插件